In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ACNAP Silver Members, Fellows of the ESC and Young combined Members

Effectiveness of community pharmacists in improving blood pressure in patients with hypertension

Session Poster Session 2

Speaker Mirela Rexhepi

Congress : EuroHeartCare 2019

  • Topic : hypertension
  • Sub-topic : Hypertension - Treatment
  • Session type : Poster Session
  • FP Number : P327

Authors : M Rexhepi (Tirana,AL), V Sanxhaku (Fier,AL), E Pistja (Lezhe,AL), R Beqaj (Tirana,AL)

M Rexhepi1 , V Sanxhaku2 , E Pistja3 , R Beqaj4 , 1University Hospital Center Mother Theresa - Tirana - Albania , 2Pharmacy Sanxhaku - Fier - Albania , 3Medical Health Training Center Santa Maria, Continuing Education - Lezhe - Albania , 4American Hospital - Tirana - Albania ,


Background: Control of hypertension has become one of the most important components of health care system programs.

Among different strategies for blood pressure control, improving adherence plays an important role for optimizing blood pressure control.

Purpose: The purpose of this study is to evaluate if a pharmaceutical care program could improve blood pressure in patients with an established diagnosis of hypertension, with a view to improve patient self- management.

Methods: This project evaluates the pharmacist's intervention during a prospective randomized controlled trial, from November 2015- to May 2016.

The study was conducted in a community pharmacy in the city of Fier/ Albania.

Patients with as established diagnosis of hypertension were allocated in 2 groups : intervention group ( follow- up by the pharmacist for 6 months)  and control group.( usual care).

Results: A total of 120 patients participated in this study. Although there were no significant differences in both groups concerning mean age, gender,body mass index and antihypertensive pharmacotherapy at the end of the study , blood pressure control  was higher in the Intervention group. ( p= 0.005).

 Medication adherence improved and also there was a decrease in the lipid levels.

Conclusion: Pharmacist intervention can significantly improve medication adherence and blood pressure control in patients with hypertension.

Community pharmacists are valuable members of multidisciplinary healthcare teams.

Also community pharmacists can participate in health education and promotion campaigns to improve hypertension control.

The free consultation period for this content is over.

It is now only available year-round to ACNAP Silver Members, Fellows of the ESC and Young combined Members

Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are